Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Hui Cong

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2021: 2 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers

Papers 5

  1. Analysis of hepatitis B virus integration identifies KMT2B as a novel cancer-related gene in pancreatic cancer. Co-author DOI 10.1002/ctm2.70424↗
  2. Upregulation of Lactobacillus spp. in gut microbiota as a novel mechanism for environmental eustress-induced anti-pancreatic cancer effects. Co-author DOI 10.1080/19490976.2025.2470372↗
  3. Increased Expression of Mitochondrial UQCRC1 in Pancreatic Cancer Impairs Antitumor Immunity of Natural Killer Cells via Elevating Extracellular ATP. Co-author DOI 10.3389/fonc.2022.872017↗
  4. E3 Ubiquitin Ligase UBR5 Promotes the Metastasis of Pancreatic Cancer via Destabilizing F-Actin Capping Protein CAPZA1. Co-author DOI 10.3389/fonc.2021.634167↗
  5. Corrigendum: E3 Ubiquitin Ligase UBR5 Promotes the Metastasis of Pancreatic Cancer via Destabilizing F-Actin Capping Protein CAPZA1. Co-author DOI 10.3389/fonc.2021.693855↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yu Gan · 5 shared papers, 2021–2025 · strength 0.78
  2. Hong Tu · 5 shared papers, 2021–2025 · strength 0.78
  3. Jin Li · 5 shared papers, 2021–2025 · strength 0.78
  4. Yiyi Liang · 4 shared papers, 2021–2025 · strength 0.58
  5. Mengge Li · 3 shared papers, 2021–2025 · strength 0.43
  6. Yuan Fang · 2 shared papers, 2021 · strength 0.22
  7. Liwei Wang · 1 shared paper, 2025 · strength 0.21
  8. Jiujie Cui · 1 shared paper, 2025 · strength 0.21
  9. Yongwei Sun · 1 shared paper, 2025 · strength 0.20
  10. Dejun Liu · 1 shared paper, 2025 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.